Clinical trial
The Canadian Study of Arterial Inflammation in Patients With Diabetes and Recent Vascular Events: EvaluatioN of Colchicine Effectiveness (CADENCE)
NCT04181996 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Canadian Study of Arterial Inflammation in Patients With Diabetes and Recent Vascular Events: EvaluatioN of Colchicine Effectiveness (CADENCE)
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 1, 2020
- Completion date
- December 16, 2025
- Enrollment
- 115 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, cardiovascular diseases, diabetes, inflammation